LAUSR

Babesiosis is caused by microscopic parasites that target red blood cells and are spread by certain ticks. The two areas of the country where tick-borne transmission is most common are the Northeast and upper Midwest, and the warm months are usually when it peaks. Although many Babesia infected people may not show symptoms, those who do can receive successful therapy. Babesiosis can be prevented by taking simple measures to reduce tick exposure [1] . Five Babesia species have been determined to be zoonotic worldwide. The epidemiology of human babesiosis is often complex and unclear due to the diversity of different Babesia species. The primary cause of human transmission of Babesia species in Europe is Ixodes ricinus . The prevalence and range of this tick suggest that human babesiosis could manifest itself wherever in Europe. The three bacteria, B. divergens , B. venatorum (EU1), and B. microti , were blamed for the clinically signi fi cant 39 recorded human cases in Europe. Regrettably, a formal identi fi cation of the Babesia species is not always possible. On the European continent, bovine B. divergens babesiosis is very common, and human cases have been reported in many nations. One human case, which happened in the Canary Islands, has been linked to B. divergens among EU abroad territories. Human babesiosis occurs primarily in the USA outside of Europe. B. microti , B. duncani n sp., and MO1-type B. sp. are pathogenic organisms. Additional cases of unidenti fi ed Babesia or B. microti have been recorded from India, Mexico, Japan, Taiwan, and Africa [2] . Babesia is not contagious and can only be passed from one person to another by a blood transfusion that has been tainted or by congenital transmission from an infected person to a fetus during pregnancy or birth. According to the Centers for Disease Control and Prevention, B. microti has